327 related articles for article (PubMed ID: 15581403)
1. Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?
Chuang DM
Crit Rev Neurobiol; 2004; 16(1-2):83-90. PubMed ID: 15581403
[TBL] [Abstract][Full Text] [Related]
2. [Neuroprotective actions of lithium].
Hashimoto R; Fujimaki K; Jeong MR; Senatorov VV; Christ L; Leeds P; Chuang DM; Takeda M
Seishin Shinkeigaku Zasshi; 2003; 105(1):81-6. PubMed ID: 12701214
[TBL] [Abstract][Full Text] [Related]
3. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.
Chuang DM
Ann N Y Acad Sci; 2005 Aug; 1053():195-204. PubMed ID: 16179524
[TBL] [Abstract][Full Text] [Related]
4. Lithium neuroprotection: molecular mechanisms and clinical implications.
Rowe MK; Chuang DM
Expert Rev Mol Med; 2004 Oct; 6(21):1-18. PubMed ID: 15488156
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of lithium in cultured cells and animal models of diseases.
Chuang DM; Chen RW; Chalecka-Franaszek E; Ren M; Hashimoto R; Senatorov V; Kanai H; Hough C; Hiroi T; Leeds P
Bipolar Disord; 2002 Apr; 4(2):129-36. PubMed ID: 12071510
[TBL] [Abstract][Full Text] [Related]
6. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease.
Senatorov VV; Ren M; Kanai H; Wei H; Chuang DM
Mol Psychiatry; 2004 Apr; 9(4):371-85. PubMed ID: 14702090
[TBL] [Abstract][Full Text] [Related]
7. Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity.
Hashimoto R; Takei N; Shimazu K; Christ L; Lu B; Chuang DM
Neuropharmacology; 2002 Dec; 43(7):1173-9. PubMed ID: 12504924
[TBL] [Abstract][Full Text] [Related]
8. Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease.
Wei H; Qin ZH; Senatorov VV; Wei W; Wang Y; Qian Y; Chuang DM
Neuroscience; 2001; 106(3):603-12. PubMed ID: 11591460
[TBL] [Abstract][Full Text] [Related]
9. Regulation of c-Jun N-terminal kinase, p38 kinase and AP-1 DNA binding in cultured brain neurons: roles in glutamate excitotoxicity and lithium neuroprotection.
Chen RW; Qin ZH; Ren M; Kanai H; Chalecka-Franaszek E; Leeds P; Chuang DM
J Neurochem; 2003 Feb; 84(3):566-75. PubMed ID: 12558976
[TBL] [Abstract][Full Text] [Related]
10. Topiramate protects against glutamate excitotoxicity via activating BDNF/TrkB-dependent ERK pathway in rodent hippocampal neurons.
Mao XY; Cao YG; Ji Z; Zhou HH; Liu ZQ; Sun HL
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jul; 60():11-7. PubMed ID: 25661849
[TBL] [Abstract][Full Text] [Related]
11. GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke.
Chuang DM; Wang Z; Chiu CT
Front Mol Neurosci; 2011; 4():15. PubMed ID: 21886605
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective action of lithium in disorders of the central nervous system.
Chiu CT; Chuang DM
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):461-76. PubMed ID: 21743136
[TBL] [Abstract][Full Text] [Related]
13. Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation.
Hashimoto R; Hough C; Nakazawa T; Yamamoto T; Chuang DM
J Neurochem; 2002 Feb; 80(4):589-97. PubMed ID: 11841566
[TBL] [Abstract][Full Text] [Related]
14. Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases.
Wada A; Yokoo H; Yanagita T; Kobayashi H
J Pharmacol Sci; 2005 Dec; 99(4):307-21. PubMed ID: 16340157
[TBL] [Abstract][Full Text] [Related]
15. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.
Manji HK; Moore GJ; Chen G
J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666
[TBL] [Abstract][Full Text] [Related]
16. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.
Chiu CT; Chuang DM
Pharmacol Ther; 2010 Nov; 128(2):281-304. PubMed ID: 20705090
[TBL] [Abstract][Full Text] [Related]
17. Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders.
Bauer M; Alda M; Priller J; Young LT;
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S250-4. PubMed ID: 14677087
[TBL] [Abstract][Full Text] [Related]
18. N-methyl-D-aspartate and TrkB receptors protect neurons against glutamate excitotoxicity through an extracellular signal-regulated kinase pathway.
Zhu D; Wu X; Strauss KI; Lipsky RH; Qureshi Z; Terhakopian A; Novelli A; Banaudha K; Marini AM
J Neurosci Res; 2005 Apr; 80(1):104-13. PubMed ID: 15744743
[TBL] [Abstract][Full Text] [Related]
19. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM
Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795
[TBL] [Abstract][Full Text] [Related]
20. Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke.
Li Y; Wu KJ; Yu SJ; Tamargo IA; Wang Y; Greig NH
Exp Neurol; 2017 Feb; 288():104-113. PubMed ID: 27856285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
